EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From Prompt to Drug: Toward Pharmaceutical Superintelligence

Alex Zhavoronkov iD, David Gennert iD, Jiye Shi

ACS Central Science · 25.03.2026 · 12 (3) · 265-279

DOI: 10.1021/acscentsci.5c01473 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Central Science, online erschienen am 02.02.2026. Verfasst von Alex Zhavoronkov und 2 weiteren Autor:innen. Beteiligte Einrichtung: Insilico Medicine US Inc, Cambridge, Massachussetts 02138, United States. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The convergence of generative artificial intelligence (AI) platforms and automated laboratory systems is ushering in a new era of drug discovery, in which a plain-language prompt can initiate a fully autonomous, end-to-end drug development program. This article explores the recent evolution of AI technologies and presents a “prompt-to-drug” pipeline, where AI not only generates novel hypotheses and designs optimized drug candidates but also orchestrates synthesis, validation, and clinical planning in a closed-loop system. By highlighting key breakthroughs, case studies, and the technological infrastructure required for this paradigm shift, we outline a vision for scalable, efficient, and unbiased drug discovery.

Autor:innen und Institutionen

  • Insilico Medicine US Inc, Cambridge, Massachussetts 02138, United States.
  • Insilico Medicine AI Ltd, Masdar City, Abu Dhabi 145748, UAE.
  • Insilico Medicine Shanghai Ltd., Shanghai 201203, China.
  • Eli Lilly and Company, San Diego, California 92121, United States.

ORCID-Profile: Alex Zhavoronkov, David Gennert

Zitieren

APA

Zhavoronkov, A., Gennert, D., & Shi, J. (2026). From Prompt to Drug: Toward Pharmaceutical Superintelligence. ACS Central Science, 12(3), 265-279. https://doi.org/10.1021/acscentsci.5c01473

Vancouver

Zhavoronkov A, Gennert D, Shi J. From Prompt to Drug: Toward Pharmaceutical Superintelligence. ACS Central Science. 2026;12(3):265-279. doi:10.1021/acscentsci.5c01473

BibTeX
@article{Zhavoronkov2026,
  author = {Zhavoronkov, Alex and Gennert, David and Shi, Jiye},
  title = {From Prompt to Drug: Toward Pharmaceutical Superintelligence},
  journal = {ACS Central Science},
  year = {2026},
  volume = {12},
  number = {3},
  pages = {265--279},
  doi = {10.1021/acscentsci.5c01473}
}
Kostenlos starten →